For: | Chen YF, Li J, Xu LL, Găman MA, Zou ZY. Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities. World J Clin Cases 2023; 11(2): 268-291 [PMID: 36686358 DOI: 10.12998/wjcc.v11.i2.268] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v11/i2/268.htm |
Number | Citing Articles |
1 |
Zhuodong Chai, Zhongyue Yuan, Yifei Chen. Stem cell status and prognostic applications of cuproptosis-associated lncRNAs in acute myeloid leukemia. Frontiers in Cell and Developmental Biology 2025; 12 doi: 10.3389/fcell.2024.1549294
|
2 |
Maedeh Rouzbahani, Seyed Amirhossein Mousavi, Ghasem Hajianfar, Ali Ghanaati, Mohammad Vaezi, Ardeshir Ghavamzadeh, Maryam Barkhordar. Predictive modeling of outcomes in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation using machine learning techniques. Leukemia Research 2025; 148: 107619 doi: 10.1016/j.leukres.2024.107619
|
3 |
Mona Rady, Maha Mostafa, Gabriel Dida, Fatima Sabet, Khaled Abou-Aisha, Carsten Watzl. Adoptive NK cell therapy in AML: progress and challenges. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01559-5
|
4 |
Yongfeng Chen, Zhenyou Zou, Mihnea-Alexandru Găman, Linglong Xu, Jing Li. NADPH oxidase mediated oxidative stress signaling in FLT3-ITD acute myeloid leukemia. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01528-5
|
5 |
Ibrahim Ethem Pinar, Serhat Celik, Merve Gokcen Polat, Aylin Fatma Karatas, Ali Dogan, Utku Iltar, Guldane Cengiz Seval, Umit Yavuz Malkan, Idris Ince, Emel Merve Yenihayat, Aydan Akdeniz, Murat Kacmaz, Ramazan Erdem, Hacer Berna Afacan Ozturk, Hakki Onur Kirkizlar, Gulten Korkmaz, Fatma Aykas, Ozgur Mehtap, Burak Deveci, Omur Gokmen Sevindik, Ferda Can, Demircan Ozbalci, Hale Bulbul, Salih Sertac Durusoy, Unal Atas, Muzaffer Keklik, Selami Kocak Toprak, Hakan Goker, Fatih Demirkan, Fahir Ozkalemkas, Inci Alacacioglu, Volkan Karakus. Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14987-z
|
6 |
Seyed Pooria Tadayon Nabavi, Mohsen Chamanara, Arasb Dabbagh Moghaddam, Mahdi Ghorbani, Reza Heidari, Mehdi Shakouri Khomartash, Javad Behroozi, Farhad Motavalli, Ali Shakerimoghaddam. Global landscape of vancomycin-resistant enterococci in hematopoietic stem-cell transplantation patients: a systematic review and meta-analysis. BMC Infectious Diseases 2024; 24(1) doi: 10.1186/s12879-024-10100-0
|
7 |
Rita Badagliacca, Manlio Fazio, Fabio Stagno, Giuseppe Mirabile, Demetrio Gerace, Alessandro Allegra. Curcumin and Acute Myeloid Leukemia: Synergistic Effects with Targeted Therapy. International Journal of Molecular Sciences 2025; 26(19): 9700 doi: 10.3390/ijms26199700
|
8 |
Nurdan Kelesoglu, Kazim Yalcin Arga. Hematological Cancer Diagnosis and Treatment: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2024; 11: 131 doi: 10.1007/16833_2024_230
|
9 |
Amelia Maria Găman. Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders. International Journal of Molecular Sciences 2023; 24(12): 9816 doi: 10.3390/ijms24129816
|
10 |
Hamed Soleimani Samarkhazan, Hanieh Noormohamadi, Fatemeh Sadat Shafiei, Niloofar Pilehvari, Amir Hossein Aghaei, Mohammad Hossein Mohammadi, Mehrnoosh Shanaki. Curcumin and acute myeloid leukemia: a golden hope, updated insights. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10692-z
|
11 |
Neha Kamboj, Rahul Kumar, Debasis Mitra. Stem Cell Therapeutics. 2025; : 409 doi: 10.1002/9781394313785.ch9
|
12 |
Zahra Khosroabadi, Samaneh Azaryar, Hassan Dianat-Moghadam, Zohreh Amoozgar, Mohammadreza Sharifi. Single cell RNA sequencing improves the next generation of approaches to AML treatment: challenges and perspectives. Molecular Medicine 2025; 31(1) doi: 10.1186/s10020-025-01085-w
|
13 |
Yong Xu, Yanli Wang. lncRNA TMEM147-AS1 promotes acute myeloid leukemia development by regulating miR-873-3p/ZFX axis. Journal of Molecular Histology 2025; 56(5) doi: 10.1007/s10735-025-10607-z
|
14 |
The Impact of the COVID-19 Pandemic on an Immunocompromised Patient with Allogeneic Haematopoietic Stem Cell Transplant: A Dual Perspective from Patient and Physician Standpoints. Oncology and Therapy 2025; doi: 10.1007/s40487-025-00364-0
|
15 |
Ze-Xi Sun. Venous thromboembolism in hematopoietic stem cell transplantation: Incidence, pathogenesis, risk stratification, and management strategies. New Cell 2025; : 1 doi: 10.61958/NCVD7814
|
16 |
Mihnea-Alexandru Găman, Vincent Kipkorir, Bahadar S. Srichawla, Arkadeep Dhali, Amelia Maria Găman, Camelia Cristina Diaconu. Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review. Biomedicines 2023; 11(2): 388 doi: 10.3390/biomedicines11020388
|
17 |
Marzieh Izadifard, Mohammad Ahmadvand, Hossein Pashaiefar, Kamran Alimoghadam, Amir Kasaeian, Maryam Barkhordar, Ghazal Seghatoleslami, Mohammad Vaezi, Ardeshir Ghavamzadeh, Marjan Yaghmaie. Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Transplantation 2024; 38(6) doi: 10.1111/ctr.15371
|
18 |
Fang Xiao, Huanxu Guo, Xueqian Yan, Meiying Qi, Jingyi Zhang. Efficacy and safety of cladribine in combination with busulfan and cyclophosphamide as an intensive conditioning regimen preceding allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia. Transplant Immunology 2024; 84: 102037 doi: 10.1016/j.trim.2024.102037
|